emerg
middl
east
respiratori
syndrom
coronaviru
merscov
mark
second
time
new
highli
pathogen
coronaviru
emerg
human
popul
st
centuri
review
discuss
current
state
knowledg
anim
model
merscov
infect
commonli
use
laboratori
anim
speci
syrian
hamster
mice
ferret
suscept
merscov
due
differ
merscov
receptor
dipeptyl
peptidas
initi
develop
anim
model
compris
two
nonhuman
primat
speci
rhesu
macaqu
common
marmoset
rhesu
macaqu
develop
mild
moder
respiratori
diseas
upon
inocul
reminisc
milder
mer
case
wherea
marmoset
develop
moder
sever
respiratori
diseas
recapitul
sever
diseas
observ
patient
dromedari
camel
consid
reservoir
merscov
develop
mild
upper
respiratori
tract
infect
abund
viral
shed
although
normal
mice
suscept
merscov
express
human
overcom
lack
suscept
transgen
mice
develop
sever
lethal
respiratori
diseas
upon
inocul
merscov
transgen
mice
potenti
ideal
first
line
anim
model
efficaci
test
therapeut
prophylact
countermeasur
character
identifi
countermeasur
would
ideal
perform
common
marmoset
model
due
sever
diseas
outcom
articl
form
part
symposium
antivir
research
sar
mer
research
highli
pathogen
human
coronavirus
middl
east
respiratori
syndrom
coronaviru
merscov
initi
identifi
fatal
case
sever
respiratori
ill
kingdom
saudi
arabia
ksa
septemb
earlier
case
retrospect
identifi
outbreak
sever
respiratori
ill
jordan
sinc
merscov
caus
laboratori
confirm
case
casefat
rate
juli
hilgenfeld
peiri
major
case
detect
ksa
lesser
extent
unit
arab
emir
uae
qatar
jordan
addit
travelassoci
mer
case
report
countri
europ
asia
africa
northamerica
recent
introduct
one
travelassoci
mer
case
south
korea
result
subsequ
hospitalassoci
outbreak
involv
case
merscov
speci
lineag
c
genu
addit
contain
bat
coronavirus
de
groot
et
al
sever
acut
respiratori
syndrom
coronaviru
sarscov
exampl
anoth
speci
genu
infect
peopl
boll
donaldson
baric
although
close
relationship
sever
bat
coronavirus
suggest
batrel
origin
overwhelm
bodi
evid
point
involv
dromedari
camel
transmiss
merscov
human
host
index
case
report
exposur
dromedari
camel
livestock
buchholz
et
al
drosten
et
al
serolog
studi
reveal
presenc
antibodi
merscov
dromedari
camel
livestock
alagaili
et
al
haagman
et
al
reusken
et
al
viru
isol
dromedari
camel
azhar
et
al
raj
et
al
inocul
dromedari
camel
merscov
result
mild
upper
respiratori
tract
infect
associ
larg
quantiti
viral
shed
adney
et
al
result
exclud
ancestr
bat
origin
merscov
might
jump
bat
speci
dromedari
camel
decad
ago
earliest
evid
merscovlik
infect
dromedari
camel
eastern
africa
detect
neutral
antibodi
sera
muller
et
al
infect
merscov
human
result
rang
differ
clinic
manifest
mild
sever
diseas
infect
frequent
associ
respiratori
diseas
although
rare
case
viral
rna
found
blood
stool
urin
suggest
system
infect
gueri
et
al
kapoor
et
al
base
detect
higher
viral
load
bronchoalveolar
lavag
bal
compar
oral
swab
viral
replic
thought
predominantli
take
place
lower
respiratori
tract
bermingham
et
al
drosten
et
al
gueri
et
al
support
radiolog
well
develop
sever
acut
respiratori
syndrom
portion
patient
broad
rang
differ
symptom
report
includ
fever
cough
sore
throat
short
breath
chest
pain
myalgia
vomit
diarrhea
sever
case
patient
present
acut
hypox
respiratori
failur
requir
mechan
ventil
underli
comorbid
obes
hypertens
diabet
mellitu
type
ii
cardiac
diseas
associ
fatal
outcom
merscov
infect
alabdallat
et
al
arabi
et
al
assiri
et
al
bermingham
et
al
yet
autopsi
data
merscovassoci
fatal
case
avail
descript
mer
progress
human
limit
clinic
data
radiograph
clinic
biochemistri
hematolog
find
imag
merscov
patient
commonli
reveal
unilater
bilater
consolid
groundglass
opac
airspac
opac
patchi
infiltr
interstiti
chang
high
number
neutrophil
macrophag
bal
document
lymphopenia
lymphocytosi
report
well
thrombocytopenia
elev
lactat
dehydrogenas
alanin
aminotransferas
aspart
transferas
creatinin
suggest
liver
kidney
gener
tissu
damag
ajlan
et
al
alabdallat
et
al
assiri
et
al
gueri
et
al
humantohuman
transmiss
merscov
seem
rel
limit
base
data
obtain
document
cluster
r
expect
number
secondari
infecti
case
gener
averag
primari
infecti
case
entir
suscept
popul
merscov
estim
breban
riou
fontanet
kucharski
althau
suggest
viru
transmiss
human
current
selflimit
cluster
transmiss
associ
hospit
set
often
lack
appropri
infect
control
measur
close
contact
alabdallat
et
al
gueri
et
al
health
protect
agenc
rel
contribut
nosocomi
transmiss
model
four
time
higher
communityacquir
infect
chowel
et
al
merscov
second
introduct
highli
pathogen
coronaviru
human
popul
st
centuri
recurr
outbreak
merscov
human
arabian
peninsula
identif
travelrel
mer
case
africa
europ
north
america
asia
highlight
need
medic
countermeasur
current
vaccin
effect
antivir
drug
exist
merscov
sarscov
human
coronaviru
preclin
develop
merscovspecif
medic
countermeasur
need
establish
anim
model
recapitul
sever
diseas
observ
human
addit
anim
model
need
dissect
underli
mechan
pathogen
merscov
studi
crossspeci
humantohuman
transmiss
continu
develop
appropri
anim
model
conduct
medic
countermeasur
research
therefor
utmost
import
small
anim
model
regularli
use
first
line
research
emerg
virus
often
viru
need
adapt
small
anim
model
interest
case
sarscov
robert
et
al
ebola
viru
bray
et
al
potenti
alter
diseasecaus
mechan
comparison
wildtyp
viru
human
host
ideal
anim
model
reproduc
hallmark
human
diseas
close
possibl
immunocompet
anim
follow
realist
dose
challeng
viru
via
appropri
inocul
rout
safronetz
geisbert
feldmann
import
compon
fda
anim
rule
concern
approv
new
drug
human
efficaci
studi
ethic
feasibl
state
fda
reli
evid
anim
studi
anim
model
use
expect
react
respons
predict
human
singl
anim
model
suffici
character
predict
human
respons
us
depart
health
human
servic
food
drug
administr
speci
close
relat
human
nonhuman
primat
greater
potenti
develop
model
predict
human
respons
diseas
outcom
importantli
evalu
specif
antivir
vaccin
diseas
model
provid
best
predict
valu
coronaviru
spike
protein
bind
cellassoci
receptor
prior
entri
specif
receptor
well
abil
protein
bind
differ
variant
receptor
determin
host
tropism
viru
graham
baric
receptor
merscov
identifi
exopeptidas
dipeptidyl
peptidas
type
ii
cell
surfac
glycoprotein
form
dimer
widespread
organ
distribut
variabl
celldepend
express
pattern
multifunct
play
role
process
cell
adhes
apoptosi
lymphocyt
stimul
lambeir
et
al
last
function
interact
adenosin
deaminas
ada
thought
import
interestingli
amino
acid
interact
ada
show
great
overlap
amino
acid
interact
merscov
protein
lu
et
al
wang
et
al
speci
evolut
need
maintain
interact
ada
might
limit
potenti
variat
interact
amino
acid
restrict
variabl
ortholog
could
explain
rel
larg
number
potenti
host
merscov
base
vitro
data
chan
et
al
chan
et
al
kindler
et
al
muller
et
al
ada
shown
compet
bind
highlight
similar
proteinprotein
contact
two
complex
raj
et
al
upon
identif
receptor
merscov
cocrystal
complex
receptor
bind
domain
rbd
perform
sever
differ
group
studi
reveal
proteinprotein
contact
mainli
mediat
hydrophil
residu
involv
blade
iv
v
rbd
homolog
sarscov
lu
et
al
wang
et
al
number
interact
amino
acid
identifi
tabl
use
predict
abil
variou
speci
function
host
merscov
van
doremalen
et
al
method
particularli
use
choos
potenti
anim
model
search
reservoir
intermedi
host
import
main
limit
factor
observ
host
tropism
merscov
shown
sever
group
vitro
shown
express
human
ortholog
nonsuscept
cell
render
suscept
wherea
case
hamster
mous
ferret
cockrel
et
al
raj
et
al
alter
five
amino
acid
hamster
two
mous
cockrel
et
al
entri
merscov
previous
nonsuscept
cell
underlin
lack
variabl
ortholog
associ
potenti
protein
adapt
differ
host
speci
common
strategi
develop
small
anim
model
adapt
viru
host
done
previous
ebola
viru
serial
passag
viru
progress
older
suckl
mice
bray
et
al
sarscov
passag
respiratori
tract
young
balbc
mice
robert
et
al
investig
six
amino
acid
mutat
mouseadapt
sarscov
identifi
singl
amino
acid
chang
within
protein
necessari
suffici
observ
increas
pathogen
compar
wildtyp
sarscov
thought
associ
increas
affin
murin
receptor
ortholog
frieman
et
al
interestingli
mous
hamster
contain
substitut
remov
highli
conserv
posit
charg
introduc
glycosyl
site
murin
glycosyl
site
shown
hindranc
cell
entri
merscov
peck
et
al
glycosyl
might
import
limit
abil
adapt
merscov
host
develop
small
anim
model
sever
small
anim
speci
evalu
abil
support
merscov
replic
variabl
degre
success
see
tabl
summari
three
differ
mous
strain
mu
musculu
develop
diseas
upon
infect
mouseadapt
sarscov
evalu
merscov
infect
model
immunocompet
balbc
mice
innat
immunedefici
mice
eightweekold
mice
strain
intranas
inocul
pb
tcid
merscov
strain
euthan
balbc
dpi
signific
weight
loss
observ
infecti
viru
could
detect
lung
mous
strain
genom
merscov
rna
detect
viral
messeng
rna
minor
patholog
lesion
sign
inflammatori
respons
observ
lung
seroposit
mice
test
togeth
data
suggest
lack
viral
replic
mice
coleman
et
al
syrian
hamster
mesocricetu
auratu
inocul
intratrach
tcid
tcid
via
aerosol
tcid
euthan
day
post
infect
none
show
clinic
sign
diseas
weight
loss
chang
bodi
temperatur
nasal
oropharyng
urogenit
fecal
swab
collect
daili
neg
viral
rna
upon
necropsi
gross
microscop
lesion
observ
viral
rna
detect
investig
tissu
final
upregul
gene
express
indic
innat
immun
respons
detect
hamster
seroconvert
ferret
mustela
putoriu
furo
suscept
sever
respiratori
pathogen
sarscov
influenza
viru
upon
inocul
ferret
tcid
viral
rna
detect
nasal
oropharyng
swab
dpi
day
thereaft
infecti
viru
detect
none
anim
seroconvert
raj
et
al
primari
rabbit
cell
well
rabbit
tissu
slice
infect
merscov
prompt
investig
feasibl
rabbit
merscov
infect
model
haagman
et
al
sixmonthold
femal
new
zealand
white
rabbit
oryctolagu
cuniculu
inocul
tcid
euthan
dpi
anim
remain
free
clinic
sign
diseas
chang
bodi
temperatur
weight
observ
experi
infecti
viru
could
detect
nasal
swab
dpi
oropharyng
swab
dpi
limit
number
sampl
infecti
viru
viral
rna
could
detect
rectal
swab
infecti
viru
low
level
could
isol
lung
tissu
wherea
viral
rna
detect
respiratori
tract
central
nervou
system
spleen
kidney
liver
intestin
gross
patholog
observ
necropsi
howev
microscop
mild
moder
rhiniti
focal
mild
moder
necrosi
observ
nasal
turbin
furthermor
moder
prolifer
bronchusassoci
lymphoid
tissu
observ
lesion
found
tissu
use
situ
hybrid
merscov
rna
detect
type
type
ii
pneumocyt
bronchiolar
epitheli
cell
nasal
epitheli
cell
merscov
antigen
detect
respiratori
epithelium
olfactori
epithelium
type
type
ii
pneumocyt
bronchial
bronchiolar
epitheli
cell
alveolar
epitheli
cell
tabl
express
merscov
antigen
seem
promin
upper
respiratori
tract
seroconvers
rabbit
observ
day
haagman
et
al
altern
adapt
merscov
mice
express
human
murin
tissu
function
model
shown
two
differ
way
transient
express
human
mous
lung
establish
infect
recombin
adenoviru
encod
human
zhao
et
al
transgen
mice
express
human
tissu
agraw
et
al
pascal
et
al
replicationdefici
adenoviru
contain
flag
myctag
human
cdna
develop
use
transduc
varieti
immunocompet
immunodefici
strain
mice
weekold
balbc
monthold
balbc
impair
rigilik
receptor
impair
tolllik
receptor
impair
ifn
signal
defici
cell
defici
b
cell
defici
b
cell
scid
mice
defici
b
cell
inocul
healthi
young
old
mice
merscov
day
inocul
adenoviru
result
merscov
replic
mortal
viru
clear
day
young
immunocompet
mice
day
old
mice
moder
weight
loss
observ
older
mice
viru
clearanc
delay
mice
compar
wt
mice
mice
defici
cell
b
cell
result
lack
clearanc
viru
zhao
et
al
use
express
cassett
transgen
mice
express
human
tissu
gener
upon
inocul
transgen
wt
mice
tcid
merscov
mice
express
wt
mice
start
lose
weight
dpi
dpi
mortal
day
postinfect
viral
shed
investig
viral
rna
could
detect
lung
brain
heart
spleen
intestin
mice
liver
kidney
infecti
viru
isol
lung
dpi
brain
dpi
investig
tissu
gross
lesion
red
dark
red
discolor
multifoc
consolid
observ
lung
mice
microscop
moder
bronchointerstiti
pneumon
observ
dpi
figur
progress
includ
intens
cellular
infiltr
dpi
patholog
chang
observ
brain
figur
viral
antigen
detect
type
type
ii
pneumocyt
brain
microglia
astrocyt
neuron
cell
figur
tabl
elev
gene
express
antivir
cytokin
proinflammatori
cytokin
chemokin
detect
qrtpcr
agraw
et
al
second
transgen
mous
model
develop
pascal
et
al
mous
replac
human
clinic
sign
mortal
observ
upon
inocul
pfu
merscov
viral
rna
well
infecti
viru
could
detect
homogen
lung
tissu
dpi
brain
tissu
dpi
peribronchiolar
inflamm
accompani
minim
perivascular
inflamm
develop
signific
interstiti
infiltr
perivascular
cuf
extens
alveolar
thicken
pascal
et
al
conclus
express
mice
suscept
infect
merscov
result
sever
diseas
two
speci
nonhuman
primat
nhp
develop
mer
anim
model
rhesu
macaqu
macaca
mulatta
munster
de
wit
feldmann
yao
et
al
common
marmoset
callithrix
jacchu
falzarano
et
al
inocul
speci
merscov
lead
viral
replic
diseas
sever
common
marmoset
rhesu
macaqu
rhesu
macaqu
first
describ
mer
anim
model
consequ
fulfil
koch
postul
confirm
merscov
caus
agent
mer
rhesu
macaqu
age
year
old
inocul
strain
either
combin
inocul
rout
oral
ocular
use
tcid
anim
observ
clinic
sign
mild
moder
appear
within
hour
transient
increas
bodi
temperatur
reduc
appetit
increas
respiratori
rate
cough
piloerect
hunch
postur
report
radiograph
imag
show
vari
degre
local
infiltr
interstiti
mark
none
anim
reach
clinic
score
requir
euthanasia
munster
et
al
yao
et
al
analysi
blood
sampl
collect
throughout
experi
reveal
increas
white
blood
cell
count
particularli
neutrophil
nasal
oropharyng
swab
posit
merscov
rna
contrast
urogenit
fecal
swab
bronchoalveolar
lavag
posit
viral
rna
detect
lung
well
conjunctiva
nasal
mucosa
tonsil
pharynx
trachea
bronchu
mediastin
lymph
node
combin
inocul
rout
use
viral
rna
detect
nonrespiratori
tissu
sampl
correl
occurr
bright
red
lesion
throughout
lower
respiratori
tract
organ
microscop
thicken
alveolar
septa
edema
fluid
fibrin
small
moder
number
macrophag
neutrophil
observ
viral
antigen
found
type
ii
pneumocyt
well
alveolar
macrophag
figur
tabl
neutral
antibodi
could
found
begin
dpi
upregul
gene
associ
proinflammatori
process
well
recruit
inflammatori
cell
note
earli
infect
decreas
time
munster
et
al
yao
et
al
potenti
use
common
marmoset
merscov
infect
model
first
investig
vitro
test
function
receptor
ortholog
merscov
silico
model
protein
bind
show
similar
bind
energi
human
marmoset
spike
wherea
model
ferret
protein
result
higher
bind
energi
indic
decreas
lack
bind
subsequ
nine
male
common
marmoset
age
year
inocul
tcid
use
combin
rout
oral
ocular
contrast
rhesu
macaqu
develop
moder
sever
sign
respiratori
diseas
includ
increas
respiratori
rate
respiratori
rate
per
minut
open
mouth
breath
loss
appetit
decreas
level
activ
failur
move
upon
prompt
presenc
oral
frothi
hemorrhag
discharg
transient
decreas
bodi
temperatur
note
dpi
two
anim
euthan
due
sever
diseas
base
clinic
symptom
remain
anim
euthan
dpi
dpi
monitor
surviv
radiograph
imag
show
mild
sever
bilater
interstiti
infiltr
case
combin
partial
full
congest
bronchiol
contrast
rhesu
macaqu
model
clinic
relev
alter
blood
cell
count
chemistri
found
anim
although
chang
could
miss
due
lack
serial
sampl
interestingli
human
case
elev
alanin
aminotransferas
aspart
transferas
creatinin
observ
although
elev
outsid
normal
marmoset
rang
nasal
oropharyng
swab
posit
merscov
rna
day
post
inocul
viral
rna
also
detect
blood
sampl
well
investig
tissu
respiratori
tract
conjunctiva
lymph
node
gastrointestin
tract
kidney
heart
adren
gland
liver
spleen
brain
least
one
anim
viral
load
found
highest
lung
signific
decreas
found
dpi
survivor
euthan
dpi
neg
tissu
infecti
viru
isol
achiev
respiratori
tissu
kidney
upon
necropsi
lesion
multifoc
consolid
dark
red
discolor
found
day
postinfect
progress
extens
sever
lesion
dpi
increas
lung
bodi
weight
ratio
compar
dpi
fluid
leak
tissu
falzarano
et
al
observ
consolid
also
report
patient
base
radiolog
find
ajlan
et
al
alabdallat
et
al
assiri
et
al
gueri
et
al
tissu
show
gross
patholog
microscop
lung
show
multifoc
coalesc
moder
mark
acut
bronchointerstiti
pneumonia
dpi
coupl
type
ii
pneumocyt
hyperplasia
consolid
pulmonari
fibrin
dpi
indic
chronic
repar
stage
pneumonia
viral
antigen
exclus
associ
region
contain
patholog
chang
found
lower
respiratori
tract
upper
respiratori
tract
primari
cell
type
merscov
replic
type
pneumocyt
alveolar
macrophag
tabl
surviv
anim
seroconvert
seen
rhesu
macaqu
upregul
gene
associ
proinflammatori
process
well
recruit
inflammatori
cell
note
falzarano
et
al
observ
diseas
marmoset
seem
recapitul
document
diseas
progress
sever
mer
case
close
rhesu
macaqu
appear
model
mild
moder
transient
mer
case
marmoset
sever
diseas
model
wherea
rhesu
macaqu
model
transient
furthermor
certain
hallmark
sever
diseas
observ
human
consolid
lung
chang
blood
chemistri
indic
liver
kidney
failur
reproduc
marmoset
model
evalu
antivir
vaccin
might
therefor
predict
marmoset
rhesu
macaqu
howev
rel
small
size
marmoset
limit
number
sampl
taken
consequ
data
obtain
within
experi
model
provid
import
insight
merscov
infect
mechan
diseas
progress
develop
desir
use
potenti
reservoir
merscov
anim
model
could
play
import
role
elucid
ecolog
transmiss
cycl
viru
dromedari
camel
experiment
infect
merscov
merscovseroneg
dromedari
camel
camelu
dromedariu
age
year
old
inocul
ocular
rout
tcid
merscov
strain
adney
et
al
mild
clinic
sign
observ
consist
rhinorrhea
persist
two
week
elev
bodi
temperatur
dpi
oropharyng
nasal
swab
posit
infecti
viru
dpi
well
viral
rna
dpi
although
viral
load
much
higher
nasal
sampl
oropharyng
sampl
viral
rna
also
detect
excret
breath
although
infecti
viru
found
infecti
viru
viral
rna
detect
urin
blood
fecal
sampl
tissu
sampl
posit
infecti
viru
dpi
dpi
interestingli
viru
mostli
found
upper
respiratori
tract
lesser
extent
lower
respiratori
tract
viru
detect
tissu
except
lymph
node
observ
lesion
respiratori
tract
dpi
character
mild
moder
acut
intraepitheli
submucos
inflamm
dpi
lesion
appear
milder
dpi
lesion
observ
line
find
viral
antigen
found
epitheli
cell
nasal
turbin
larynx
trachea
bronchi
bronchiol
alveoli
dpi
figur
limit
nasal
turbin
dpi
found
dpi
neutral
antibodi
detect
start
dpi
light
recent
outbreak
south
korea
ongo
outbreak
saudi
arabia
develop
countermeasur
antivir
vaccin
import
although
thousand
case
merscov
detect
overal
transmiss
potenti
viru
limit
mostli
observ
hospit
set
alabdallat
et
al
assiri
et
al
gueri
et
al
health
protect
agenc
widespread
vaccin
merscov
endem
area
seem
current
unnecessari
instead
potenti
vaccin
program
focu
individu
risk
contract
spread
merscov
two
differ
group
qualifi
approach
atrisk
group
consist
peopl
immunocompromis
health
issu
comorbid
diabet
peopl
commonli
expos
viru
via
workrel
activ
anim
handler
healthcar
provid
recent
crosssect
serolog
studi
saudi
arabia
found
seropreval
increas
time
shepherd
time
slaughterhous
worker
compar
gener
popul
provid
support
potenti
vaccin
approach
muller
et
al
altern
vaccin
approach
would
prevent
zoonot
transmiss
vaccin
young
camel
therebi
reduc
limit
exposur
human
merscov
sever
studi
current
look
potenti
develop
camel
vaccin
merscov
countermeasur
block
cameltohuman
transmiss
kupferschmidt
anim
model
play
pivot
role
develop
vaccin
mice
model
perfect
firstlin
model
investig
correl
protect
vaccin
particular
import
coronavirus
coronaviru
vaccin
show
immunemedi
enhanc
diseas
socal
vaccineinduc
immunopotenti
vaccin
vaccineinduc
immun
anim
atyp
wane
quickli
subsequ
infect
agent
interest
result
increas
patholog
compar
unvaccin
anim
deme
et
al
vennema
et
al
sarscov
effect
thought
caus
incorpor
sarscov
nucleocapsid
protein
result
induct
atyp
adapt
immun
respons
consequ
eosinophil
immunopatholog
rather
immun
respons
associ
natur
sarscov
infect
boll
et
al
tseng
et
al
tsunetsuguyokota
et
al
wong
et
al
yasui
et
al
immunogen
merscov
vaccin
candid
evalu
nonsuscept
mice
coleman
et
al
guo
et
al
tang
et
al
zhao
et
al
use
venezuelan
equin
enceph
replicon
particl
express
merscov
protein
vrp
vaccin
method
immun
vrp
use
primeboost
regimen
reduc
merscov
titer
nearli
undetect
level
day
pi
zhao
et
al
volz
et
al
tabl
therapeut
option
hand
need
develop
treatment
sick
individu
aim
directli
treat
symptom
well
increas
surviv
rate
associ
merscov
infect
potenti
fasttrack
countermeasur
repurpos
exist
therapeut
first
merscov
treatment
studi
investig
two
exist
antivir
drug
ribavirin
efficaci
combin
treatment
ribavirin
shown
vitro
falzarano
et
al
vivo
efficaci
verifi
rhesu
macaqu
upon
treatment
ribavirin
eight
hour
postinfect
anim
show
much
milder
diseas
compar
untreat
infect
macaqu
mild
radiograph
evid
pneumonia
decreas
proinflammatori
marker
decreas
viral
load
less
sever
histopatholog
chang
lung
studi
suggest
treatment
merscovinfect
rhesu
macaqu
ribavirin
improv
outcom
infect
convalesc
plasma
administr
identifi
potenti
treatment
option
administr
convalesc
plasma
significantli
reduc
viral
titer
lung
sensit
mice
day
post
challeng
merscov
zhao
et
al
likewis
convalesc
sera
obtain
camel
decreas
patholog
chang
increas
viral
clearanc
lung
mice
sensit
merscov
final
administr
monoclon
antibodi
transgen
mice
express
human
place
mous
one
day
one
day
challeng
merscov
result
signific
decreas
viral
titer
lung
compar
control
pascal
et
al
tabl
studi
like
urgent
need
develop
treatment
option
hospit
merscov
infect
individu
although
varieti
anim
speci
test
merscov
infect
model
nhp
model
mice
show
sever
clinic
symptom
upon
inocul
model
need
util
develop
prophylact
therapeut
medic
countermeasur
develop
transgen
mous
model
provid
easytous
rel
cheap
access
firstlin
model
addit
marmoset
model
seem
appropri
test
potenti
differ
treatment
option
identifi
transgen
mous
model
monoclon
antibodi
develop
reservoir
model
dromedari
camel
provid
crucial
insight
ecolog
transmiss
merscov
addit
dromedari
camel
model
merscov
infect
help
determin
feasibl
reservoir
vaccin
countermeasur
merscov
differ
cell
tissu
tropism
upper
lower
respiratori
tract
dromedari
camel
nhp
observ
highlight
figur
differ
could
explain
differ
sever
diseas
could
instrument
further
understand
pathogenesi
well
transmiss
potenti
merscov
realiz
potenti
limit
anim
model
discuss
review
result
better
understand
merscov
ecolog
develop
medic
countermeasur
number
mer
case
still
rise
ongo
research
differ
anim
model
potenti
countermeasur
crucial
merscov
infect
patient
date
associ
case
fatal
rate
approxim
anim
rang
mice
rabbit
nonhuman
primat
inocul
merscov
vari
outcom
mice
express
human
suscept
infect
develop
sever
diseas
rhesu
macaqu
marmoset
also
suscept
marmoset
develop
sever
diseas
develop
appropri
anim
model
conduct
medic
countermeasur
research
public
health
prioriti
patholog
lung
brain
tissu
upon
inocul
merscov
transgen
human
mice
histopatholog
chang
viral
antigen
stain
lung
brain
b
tissu
normal
mice
transgen
human
mice
tg
infect
merscov
two
four
b
dpi
imag
obtain
agraw
et
al
agraw
et
al
reprint
permiss
immunohistochem
analys
respiratori
tract
tissu
dromedari
camel
rhesu
macaqu
inocul
merscov
width
color
intens
left
right
triangl
indic
distribut
merscov
antigen
throughout
respiratori
tract
dark
red
wider
antigen
light
red
narrow
less
antigen
panel
dromedari
camel
viral
antigen
stain
mostli
found
nasal
turbin
lesser
extend
trachea
bronchi
ciliat
pseudostratifi
columnar
epitheli
cell
bronchiol
rare
ciliat
columnar
epitheli
cell
stain
detect
panel
rhesu
macaqu
viral
antigen
stain
found
type
ii
pneumocyt
occasion
alveolar
macrophag
alveoli
tabl
amino
acid
residu
differ
ortholog
interact
protein
merscov
nd
nd
viral
load
determin
qrtpcr
upe
assay
corman
et
al
rr
respiratori
rate
nc
nasal
caviti
nasal
turbin
andor
nasal
mucosa
urt
upper
respiratori
tract
nasal
turbin
mucosa
pharynx
larynx
lrt
lower
respiratori
tract
trachea
lung
bronchi
bronchiol
alveoli
nd
detect
done
intratrach
intranas
van
doremalen
munster
page
tabl
summari
characterist
rhesu
macaqu
marmoset
model
mer
challeng
mild
mark
interstiti
pneumonia
extens
bronchointerstiti
pneumonia
